Sectors

Illumina and Celgene could exit genome researcher Human Longevity in a reverse merger while Openly raised $75m from investors including Advance Venture Partners and Gradient Ventures.

Woven Capital managing director George Kellerman tells GCV about the fund and how it works with Toyota Ventures and Toyota ahead of his spotlight interview on the first day of this year’s GCVI Summit.

Asian, fintech-focused and less than seven years old – some of the CVC trends we saw when compiling the Global Corporate Venturing Directory.

Gene-sequencing technology producer Axbio raised nearly $100m in a round co-led by AstraZeneca-CICC Investment Fund while Eli Lilly helped Forbion Growth Opportunities Fund II to a $504m first close.

Stanley Black & Decker's investment arm is shifting focus as its parent prepares to divest its healthcare and security assets in favour of a newly created outdoor products business, according to president Dina Routhier.

The Chinese ride-hailing company's pullback from US markets emblematic of a shift to more geopolitically divided capital.

Ascenion and Goethe University Frankfurt are among the initiators of Carma Fund I, which will help start up and fund early life science projects.

The motorised product manufacturer will invest in environmental technology developers through its newly formed Sustainability Fund.

Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.

The carmaker is exploring a "car for life" that gets upgraded as your needs change and other ideas at a new innovation centre it has set up at Warwick University.

Cancer biopsy developer Elypta raised $21m in a round led by Bonnier Ventures while Evli Bank led cryptocurrency arbitrage platform Mosdex's $20m series A.